Cargando…

Neuroleptic malignant syndrome following reintroduction of an antipsychotic after overdose

Neuroleptic malignant syndrome (NMS) is a potentially lethal adverse drug reaction. We report a case of NMS potentially induced by dehydration in a female patient suffering from schizoaffective disorder. We discuss possible aetiologies and triggering factors alongside the existing literature.

Detalles Bibliográficos
Autores principales: Korchia, Théo, Blackman, Graham, Cermolacce, Michel, Richieri, Raphaëlle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078231/
https://www.ncbi.nlm.nih.gov/pubmed/30076161
http://dx.doi.org/10.1136/bcr-2017-223922
_version_ 1783345055147229184
author Korchia, Théo
Blackman, Graham
Cermolacce, Michel
Richieri, Raphaëlle
author_facet Korchia, Théo
Blackman, Graham
Cermolacce, Michel
Richieri, Raphaëlle
author_sort Korchia, Théo
collection PubMed
description Neuroleptic malignant syndrome (NMS) is a potentially lethal adverse drug reaction. We report a case of NMS potentially induced by dehydration in a female patient suffering from schizoaffective disorder. We discuss possible aetiologies and triggering factors alongside the existing literature.
format Online
Article
Text
id pubmed-6078231
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-60782312018-08-10 Neuroleptic malignant syndrome following reintroduction of an antipsychotic after overdose Korchia, Théo Blackman, Graham Cermolacce, Michel Richieri, Raphaëlle BMJ Case Rep Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions Neuroleptic malignant syndrome (NMS) is a potentially lethal adverse drug reaction. We report a case of NMS potentially induced by dehydration in a female patient suffering from schizoaffective disorder. We discuss possible aetiologies and triggering factors alongside the existing literature. BMJ Publishing Group 2018-08-03 /pmc/articles/PMC6078231/ /pubmed/30076161 http://dx.doi.org/10.1136/bcr-2017-223922 Text en © BMJ Publishing Group Limited 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions
Korchia, Théo
Blackman, Graham
Cermolacce, Michel
Richieri, Raphaëlle
Neuroleptic malignant syndrome following reintroduction of an antipsychotic after overdose
title Neuroleptic malignant syndrome following reintroduction of an antipsychotic after overdose
title_full Neuroleptic malignant syndrome following reintroduction of an antipsychotic after overdose
title_fullStr Neuroleptic malignant syndrome following reintroduction of an antipsychotic after overdose
title_full_unstemmed Neuroleptic malignant syndrome following reintroduction of an antipsychotic after overdose
title_short Neuroleptic malignant syndrome following reintroduction of an antipsychotic after overdose
title_sort neuroleptic malignant syndrome following reintroduction of an antipsychotic after overdose
topic Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078231/
https://www.ncbi.nlm.nih.gov/pubmed/30076161
http://dx.doi.org/10.1136/bcr-2017-223922
work_keys_str_mv AT korchiatheo neurolepticmalignantsyndromefollowingreintroductionofanantipsychoticafteroverdose
AT blackmangraham neurolepticmalignantsyndromefollowingreintroductionofanantipsychoticafteroverdose
AT cermolaccemichel neurolepticmalignantsyndromefollowingreintroductionofanantipsychoticafteroverdose
AT richieriraphaelle neurolepticmalignantsyndromefollowingreintroductionofanantipsychoticafteroverdose